LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

(Evan Lorne/Shutterstock.com)
GILLIAN RICH9:16 AM EST
LinkedIn (LNKD) was downgraded Friday after reporting weak guidance Thursday. Celgene (CELG) and other biotechs were started with a market perform rating.

LinkedIn was downgraded to sector perform from outperform by RBC Capital Markets. The professional social networking site beat Q4 estimates but guided Q1 and earnings below views.


Shares plunged 22.7% to 127.50 in premarket trading in the stock market today.

Leerink Swann started Amgen (AMGN), Biogen (BIIB) and Celgene with market perform ratings.


Amgen, Biogen and Celgene shares weren’t active early.

Tableau Software‘s (DATA)price price target was cut to 75 from 130 at Wunderlich Securities. Goldman Sachs cut its price target on the stock to 61 from 99. Baird maintained its outperform rating on Tableau but lowered the price target to 80.

On Thursday the maker of Big Data analytics software guided Q1 losses and revenue below consensus forecasts.

Analysts say consumers want products like Amazon‘s (AMZN) AWS QuickSight vs. Tableau’s offerings.

Tableau shares tumbled 39.1% to 49.80.
投行降级，竞争加剧，我觉得本质是市场情绪很脆弱。

为何暴跌？财报？

画面很血腥，mark